These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9331725)

  • 1. Studies on variation in Lancefield group A type 50 streptococcal cell-wall carbohydrate.
    Kurl DN
    Adv Exp Med Biol; 1997; 418():607-10. PubMed ID: 9331725
    [No Abstract]   [Full Text] [Related]  

  • 2. Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.
    Zabriskie JB; Poon-King T; Blake MS; Michon F; Yoshinaga M
    Adv Exp Med Biol; 1997; 418():917-9. PubMed ID: 9331798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A
    Henningham A; Davies MR; Uchiyama S; van Sorge NM; Lund S; Chen KT; Walker MJ; Cole JN; Nizet V
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The persistence and biodegradation of the cell walls of Streptococcus group A in light of the immunopathogenesis of nonsuppurative poststreptococcal diseases].
    Shikhman AR; Cherniakova AM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Feb; (2):74-80. PubMed ID: 2188468
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of cryptic epitopes in designing a group A streptococcal vaccine.
    Ozberk V; Pandey M; Good MF
    Hum Vaccin Immunother; 2018; 14(8):2034-2052. PubMed ID: 29873591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes.
    Unnikrishnan M; Altmann DM; Proft T; Wahid F; Cohen J; Fraser JD; Sriskandan S
    J Immunol; 2002 Sep; 169(5):2561-9. PubMed ID: 12193726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR; Dramaix M; Van Melderen L
    Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033
    [No Abstract]   [Full Text] [Related]  

  • 8. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.
    van Sorge NM; Cole JN; Kuipers K; Henningham A; Aziz RK; Kasirer-Friede A; Lin L; Berends ETM; Davies MR; Dougan G; Zhang F; Dahesh S; Shaw L; Gin J; Cunningham M; Merriman JA; Hütter J; Lepenies B; Rooijakkers SHM; Malley R; Walker MJ; Shattil SJ; Schlievert PM; Choudhury B; Nizet V
    Cell Host Microbe; 2014 Jun; 15(6):729-740. PubMed ID: 24922575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease.
    Akesson P; Rasmussen M; Mascini E; von Pawel-Rammingen U; Janulczyk R; Collin M; Olsen A; Mattsson E; Olsson ML; Bjorck L; Christensson B
    J Infect Dis; 2004 Mar; 189(5):797-804. PubMed ID: 14976595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group A, B, C, and G
    Zorzoli A; Meyer BH; Adair E; Torgov VI; Veselovsky VV; Danilov LL; Uhrin D; Dorfmueller HC
    J Biol Chem; 2019 Oct; 294(42):15237-15256. PubMed ID: 31506299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of the Classical Lancefield Group A Streptococcal Carbohydrate Antigen.
    Gao NJ; Rodas Lima E; Nizet V
    Infect Immun; 2021 Nov; 89(12):e0029221. PubMed ID: 34543125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.
    Zhang S; Green NM; Sitkiewicz I; Lefebvre RB; Musser JM
    Infect Immun; 2006 Jul; 74(7):4200-13. PubMed ID: 16790795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Streptococcus pyogenes--pathogenetic factors and their involvement in the pathogenesis of acute streptococcal infections and their complications].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):34-47. PubMed ID: 8173211
    [No Abstract]   [Full Text] [Related]  

  • 14. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
    Kaminskiĭ GD; Beliakov VD
    Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of the classical Lancefield assay of group A streptococcal killing to reduce inter-donor variation.
    Reglinski M; Lynskey NN; Sriskandan S
    J Microbiol Methods; 2016 May; 124():69-71. PubMed ID: 27030640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quest for GAS vaccine.
    Pandey M; Good MF
    Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive group A streptococcal infection with pancarditis caused by a new emm-type 12 allele of Streptococcus pyogenes.
    Ozkaya G; Shorbagi A; Ulger Z; Saglam A; Aybar M; Sardan YC; Uzun O
    J Infect; 2006 Jul; 53(1):e1-4. PubMed ID: 16364444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simposium sobre estreptococo, fiebre reumática y glomerulonefritis. The biology of group A streptococci.
    McCarty M
    Arch Inst Cardiol Mex; 1979; 49(1):68-73. PubMed ID: 373655
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever.
    Read SE; Fischetti VA; Utermohlen V; Falk RE; Zabriskie JB
    J Clin Invest; 1974 Aug; 54(2):439-50. PubMed ID: 4603169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.